Fatemi H

No ORCID on file · 8 papers in corpus
diagnostic-accuracy 2026
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-026-04020-y

PURPOSE: To study whether there is a marked interobserver discrepancy in the diagnosis of adenomyosis based on reviewing stored sonographic images of infertile patients? METHODS: Three reproductive endocrinology and infertility specialists…

review 2026
Frontiers in reproductive health ·doi:10.3389/frph.2026.1738726

BACKGROUND: Declining fertility rates are a globally documented problem, affecting even regions that have historically high fertility rates. In the Asia Pacific (APAC) region, most countries and territories are seeing birth rates drop far b…

case-report 2025
BMJ case reports ·doi:10.1136/bcr-2025-267402

A patient of advanced maternal age with infertility underwent assisted reproductive technology treatment, followed by a single euploid embryo transfer in a hormonal replacement therapy frozen cycle. The implanted embryo resulted in a thorac…

observational 2025
Frontiers in endocrinology ·doi:10.3389/fendo.2025.1654365

INTRODUCTION: Anti-Müllerian Hormone (AMH) and antral follicle count (AFC) are commonly used markers of ovarian reserve, yet their predictive accuracy in patients with low ovarian reserve remains limited. This study aimed to evaluate whethe…

review 2025
Frontiers in reproductive health ·doi:10.3389/frph.2025.1605480

BACKGROUND: Infertility is an underrecognized disease which affects over 17% of the reproductive age population worldwide. However, availability of, and access to, assisted reproductive technology (ART) is variable across countries. There a…

review 2025
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2024.104444

Adenomyosis is an important clinical condition with uncertain prevalence, and clinical focus on adenomyosis in patients undergoing assisted reproductive technology (ART) has increased during recent years. Recognizing the limited clinical kn…

observational 2023
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-023-02805-z

PURPOSE: The objective of this study was to investigate whether women with diminished ovarian reserve who planned for PGT-A exhibit a lower number of blastocysts for biopsy, ploidy outcomes, and blastocyst quality on day 5, regardless of ag…

other 2022
Frontiers in endocrinology ·doi:10.3389/fendo.2022.857089